Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 951-975 of 1,000 matching filings.

Per page
25
Current page
39
8-K File 001-12465

FORM 8-K

Filing date
27 Jun 2013
Reporting date
27 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-189611

FORM S-8

Filing date
26 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
24 Jun 2013
Reporting date
17 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2013
Reporting date
05 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2013
Reporting date
31 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2013
Reporting date
31 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2013
Reporting date
30 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

DEFINITIVE ADDITIONAL MATERIALS

Filing date
31 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
31 May 2013
Reporting date
31 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 May 2013
Reporting date
24 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

DEFINITIVE ADDITIONAL MATERIALS

Filing date
13 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12465

DEFINITIVE PROXY STATEMENT

Filing date
13 May 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2013
Reporting date
08 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
02 May 2013
Reporting date
02 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-12465

PRELIMINARY PROXY STATEMENT

Filing date
01 May 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
30 Apr 2013
Reporting date
30 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
09 Apr 2013
Reporting date
09 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

FORM 8-K

Filing date
09 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

SOLICITING MATERIAL

Filing date
08 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

8-K

Filing date
29 Mar 2013
Reporting date
29 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
28 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
27 Mar 2013
Reporting date
06 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .